Your browser doesn't support javascript.
loading
Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial.
van Meenen, David M P; van der Hoeven, Sophia M; Binnekade, Jan M; de Borgie, Corianne A J M; Merkus, Maruschka P; Bosch, Frank H; Endeman, Henrik; Haringman, Jasper J; van der Meer, Nardo J M; Moeniralam, Hazra S; Slabbekoorn, Mathilde; Muller, Marcella C A; Stilma, Willemke; van Silfhout, Bart; Neto, Ary Serpa; Ter Haar, Hans F M; Van Vliet, Jan; Wijnhoven, Jan Willem; Horn, Janneke; Juffermans, Nicole P; Pelosi, Paolo; Gama de Abreu, Marcelo; Schultz, Marcus J; Paulus, Frederique.
Afiliación
  • van Meenen DMP; Department of Intensive Care, Academic Medical Center, University of Amsterdam, the Netherlands.
  • van der Hoeven SM; Department of Intensive Care, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Binnekade JM; Department of Intensive Care, Academic Medical Center, University of Amsterdam, the Netherlands.
  • de Borgie CAJM; Clinical Research Unit, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Merkus MP; Clinical Research Unit, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Bosch FH; Department of Intensive Care, Rijnstate, Arnhem, the Netherlands.
  • Endeman H; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • Haringman JJ; Department of Intensive Care, Isala Hospital, Zwolle, the Netherlands.
  • van der Meer NJM; Department of Intensive Care, Amphia Hospital, Breda, the Netherlands.
  • Moeniralam HS; Department of Intensive Care, Antonius Hospital, Nieuwegein, the Netherlands.
  • Slabbekoorn M; Department of Intensive Care, Haaglanden Medical Center, The Hague, the Netherlands.
  • Muller MCA; Department of Intensive Care, Haaglanden Medical Center, The Hague, the Netherlands.
  • Stilma W; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • van Silfhout B; Department of Intensive Care, Antonius Hospital, Nieuwegein, the Netherlands.
  • Neto AS; Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Ter Haar HFM; Department of Intensive Care, Isala Hospital, Zwolle, the Netherlands.
  • Van Vliet J; Department of Intensive Care, Rijnstate, Arnhem, the Netherlands.
  • Wijnhoven JW; Department of Intensive Care, Amphia Hospital, Breda, the Netherlands.
  • Horn J; Department of Intensive Care, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Juffermans NP; Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Pelosi P; Department of Intensive Care, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Gama de Abreu M; Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Schultz MJ; Department of Surgical Sciences and Integrated Diagnostics, San Martino Policlinico Hospital, IRCCS for Oncology, University of Genoa, Genoa, Italy.
  • Paulus F; Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus; Technische Universität Dresden, Dresden, Germany.
JAMA ; 319(10): 993-1001, 2018 03 13.
Article en En | MEDLINE | ID: mdl-29486489
ABSTRACT
Importance It remains uncertain whether nebulization of mucolytics with bronchodilators should be applied for clinical indication or preventively in intensive care unit (ICU) patients receiving invasive ventilation.

Objective:

To determine if a strategy that uses nebulization for clinical indication (on-demand) is noninferior to one that uses preventive (routine) nebulization. Design, Setting, and

Participants:

Randomized clinical trial enrolling adult patients expected to need invasive ventilation for more than 24 hours at 7 ICUs in the Netherlands.

Interventions:

On-demand nebulization of acetylcysteine or salbutamol (based on strict clinical indications, n = 471) or routine nebulization of acetylcysteine with salbutamol (every 6 hours until end of invasive ventilation, n = 473). Main Outcomes and

Measures:

The primary outcome was the number of ventilator-free days at day 28, with a noninferiority margin for a difference between groups of -0.5 days. Secondary outcomes included length of stay, mortality rates, occurrence of pulmonary complications, and adverse events.

Results:

Nine hundred twenty-two patients (34% women; median age, 66 (interquartile range [IQR], 54-75 years) were enrolled and completed follow-up. At 28 days, patients in the on-demand group had a median 21 (IQR, 0-26) ventilator-free days, and patients in the routine group had a median 20 (IQR, 0-26) ventilator-free days (1-sided 95% CI, -0.00003 to ∞). There was no significant difference in length of stay or mortality, or in the proportion of patients developing pulmonary complications, between the 2 groups. Adverse events (13.8% vs 29.3%; difference, -15.5% [95% CI, -20.7% to -10.3%]; P < .001) were more frequent with routine nebulization and mainly related to tachyarrhythmia (12.5% vs 25.9%; difference, -13.4% [95% CI, -18.4% to -8.4%]; P < .001) and agitation (0.2% vs 4.3%; difference, -4.1% [95% CI, -5.9% to -2.2%]; P < .001). Conclusions and Relevance Among ICU patients receiving invasive ventilation who were expected to not be extubated within 24 hours, on-demand compared with routine nebulization of acetylcysteine with salbutamol did not result in an inferior number of ventilator-free days. On-demand nebulization may be a reasonable alternative to routine nebulization. Trial Registration clinicaltrials.gov Identifier NCT02159196.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acetilcisteína / Respiración Artificial / Nebulizadores y Vaporizadores / Cuidados Críticos / Albuterol Tipo de estudio: Clinical_trials Idioma: En Revista: JAMA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acetilcisteína / Respiración Artificial / Nebulizadores y Vaporizadores / Cuidados Críticos / Albuterol Tipo de estudio: Clinical_trials Idioma: En Revista: JAMA Año: 2018 Tipo del documento: Article